The University of Chicago Header Logo

Connection

Mai Pho to Humans

Back to Details
This is a "connection" page, showing publications Mai Pho has written about Humans.
Mai Pho
Connection Strength
0.630
Humans
  1. DoxyPEP: Opportunities for Expansion. J Prim Care Community Health. 2025 Jan-Dec; 16:21501319251370497.
    View in: PubMed
    Score: 0.031
  2. Implementation strategies to support recovery support workers serving criminal legal involved people who use drugs. J Subst Use Addict Treat. 2025 Feb; 169:209583.
    View in: PubMed
    Score: 0.029
  3. Medicaid Policy and Hepatitis C Treatment Among Rural People Who Use Drugs. Med Care. 2025 Feb 01; 63(2):77-88.
    View in: PubMed
    Score: 0.029
  4. Accessibility of Naloxone in Pharmacies Registered Under the Illinois Standing Order. West J Emerg Med. 2024 Jul; 25(4):457-464.
    View in: PubMed
    Score: 0.028
  5. How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States. Int J Drug Policy. 2023 02; 112:103930.
    View in: PubMed
    Score: 0.025
  6. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois. Harm Reduct J. 2022 11 19; 19(1):128.
    View in: PubMed
    Score: 0.025
  7. Structural and community changes during COVID-19 and their effects on overdose precursors among rural people who use drugs: a mixed-methods analysis. Addict Sci Clin Pract. 2022 04 25; 17(1):24.
    View in: PubMed
    Score: 0.024
  8. The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings. Int J Environ Res Public Health. 2022 02 16; 19(4).
    View in: PubMed
    Score: 0.024
  9. Reducing Opioid Mortality in Illinois (ROMI): A case management/peer recovery coaching critical time intervention clinical trial protocol. J Subst Abuse Treat. 2021 09; 128:108348.
    View in: PubMed
    Score: 0.022
  10. Stigmatize the use, not the user? Attitudes on opioid use, drug injection, treatment, and overdose prevention in rural communities. Soc Sci Med. 2021 01; 268:113470.
    View in: PubMed
    Score: 0.022
  11. Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19. Obesity (Silver Spring). 2020 10; 28(10):1806-1810.
    View in: PubMed
    Score: 0.022
  12. Opioid Prescribing Patterns Before Fatal Opioid Overdose. Am J Prev Med. 2020 02; 58(2):250-253.
    View in: PubMed
    Score: 0.021
  13. Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose. JAMA Netw Open. 2019 05 03; 2(5):e193209.
    View in: PubMed
    Score: 0.020
  14. Health Care Utilization of Opioid Overdose Decedents with No Opioid Analgesic Prescription History. J Urban Health. 2019 02; 96(1):38-48.
    View in: PubMed
    Score: 0.019
  15. Clinical impact of treatment timing for chronic hepatitis C infection: a decision model. J Viral Hepat. 2015 Aug; 22(8):630-8.
    View in: PubMed
    Score: 0.015
  16. Optimizing tuberculosis case detection through a novel diagnostic device placement model: the case of Uganda. PLoS One. 2015; 10(4):e0122574.
    View in: PubMed
    Score: 0.015
  17. Valuing cure: bridging cost-effectiveness and coverage decisions for hepatitis C therapy. Hepatology. 2014 Jul; 60(1):12-4.
    View in: PubMed
    Score: 0.014
  18. The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis. PLoS One. 2012; 7(4):e36001.
    View in: PubMed
    Score: 0.012
  19. Right buttock rash for thirty years in a patient from China. Clin Infect Dis. 2009 Aug 01; 49(3):432, 477-8.
    View in: PubMed
    Score: 0.010
  20. Benzodiazepines and Opioid co-use Among Rural People Who Use Drugs: Findings From the Rural Opioid Initiative. Subst Use Addctn J. 2025 Oct; 46(4):847-858.
    View in: PubMed
    Score: 0.007
  21. Barriers to accessing medications for opioid use disorder among rural individuals. Int J Drug Policy. 2025 Jun; 140:104805.
    View in: PubMed
    Score: 0.007
  22. Sexual identity, sexual behavior, and drug use behaviors among people who use drugs in the rural U.S. J Subst Use Addict Treat. 2025 Apr; 171:209629.
    View in: PubMed
    Score: 0.007
  23. I Don't Want to Shoot up the Meth Anymore: Pipe Distribution as a Harm Reduction Service for People Who Use Methamphetamine. Subst Use Misuse. 2025; 60(4):558-565.
    View in: PubMed
    Score: 0.007
  24. Differences in hepatitis C virus (HCV) testing and treatment by opioid, stimulant, and polysubstance use among people who use drugs in rural U.S. communities. Harm Reduct J. 2024 Nov 29; 21(1):214.
    View in: PubMed
    Score: 0.007
  25. Rural houselessness among people who use drugs in the United States: Results from the National Rural Opioid Initiative. Drug Alcohol Depend. 2025 Jan 01; 266:112498.
    View in: PubMed
    Score: 0.007
  26. Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative. Harm Reduct J. 2024 Aug 24; 21(1):154.
    View in: PubMed
    Score: 0.007
  27. Barriers to Healthcare and Social Service Utilization Among Rural Older Adults Who Use Drugs. J Appl Gerontol. 2024 12; 43(12):1977-1984.
    View in: PubMed
    Score: 0.007
  28. Evaluation of respondent-driven sampling in seven studies of people who use drugs from rural populations: findings from the Rural Opioid Initiative. BMC Med Res Methodol. 2024 Apr 23; 24(1):94.
    View in: PubMed
    Score: 0.007
  29. Opioid use, prescribing and fatal overdose patterns among racial/ethnic minorities in the United States: A scoping review and conceptual risk environment model. Drug Alcohol Rev. 2024 Jul; 43(5):1143-1159.
    View in: PubMed
    Score: 0.007
  30. How do people who use opioids express their qualities and capacities? An assessment of attitudes, behaviors, and opportunities. Harm Reduct J. 2024 04 08; 21(1):79.
    View in: PubMed
    Score: 0.007
  31. Recent Incarceration, Substance Use, Overdose, and Service Use Among People Who Use Drugs in Rural Communities. JAMA Netw Open. 2023 11 01; 6(11):e2342222.
    View in: PubMed
    Score: 0.007
  32. Houselessness and syringe service program utilization among people who inject drugs in eight rural areas across the USA: a cross-sectional analysis. Harm Reduct J. 2023 10 26; 20(1):157.
    View in: PubMed
    Score: 0.007
  33. Associations of hepatitis C virus (HCV) antibody positivity with opioid, stimulant, and polysubstance injection among people who inject drugs (PWID) in rural U.S. communities. Int J Drug Policy. 2025 Jul; 141:104222.
    View in: PubMed
    Score: 0.007
  34. Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs. Drug Alcohol Depend. 2023 09 01; 250:110911.
    View in: PubMed
    Score: 0.007
  35. I Don't Believe a Person Has to Die When Trying to Get High: Overdose Prevention and Response Strategies in Rural Illinois. Int J Environ Res Public Health. 2023 01 16; 20(2).
    View in: PubMed
    Score: 0.006
  36. The Rural Opioid Initiative Consortium description: providing evidence to Understand the Fourth Wave of the Opioid Crisis. Addict Sci Clin Pract. 2022 07 26; 17(1):38.
    View in: PubMed
    Score: 0.006
  37. Medical Student Screening for Naloxone Eligibility in the Emergency Department: A Value-Added Role to Fight the Opioid Epidemic. MedEdPORTAL. 2021; 17:11196.
    View in: PubMed
    Score: 0.006
  38. Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission. BMC Infect Dis. 2021 Jun 02; 21(1):516.
    View in: PubMed
    Score: 0.006
  39. Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience. Clin Infect Dis. 2021 04 26; 72(8):1450-1452.
    View in: PubMed
    Score: 0.006
  40. Point-of-care naloxone distribution in the emergency department: A pilot study. Am J Health Syst Pharm. 2021 02 08; 78(4):360-366.
    View in: PubMed
    Score: 0.006
  41. Health economic analyses of the justice community opioid innovation network (JCOIN). J Subst Abuse Treat. 2021 09; 128:108262.
    View in: PubMed
    Score: 0.006
  42. Comparison of effectiveness and cost for different HIV screening strategies implemented at large urban medical centre in the United States. J Int AIDS Soc. 2020 10; 23(10):e25554.
    View in: PubMed
    Score: 0.005
  43. Rural risk environments, opioid-related overdose, and infectious diseases: A multidimensional, spatial perspective. Int J Drug Policy. 2020 11; 85:102727.
    View in: PubMed
    Score: 0.005
  44. COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities. J Rural Health. 2021 01; 37(1):172-174.
    View in: PubMed
    Score: 0.005
  45. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois. AIDS Patient Care STDS. 2020 08; 34(8):331-335.
    View in: PubMed
    Score: 0.005
  46. Improving Shared Decision Making For Asian American Pacific Islander Sexual and Gender Minorities. Med Care. 2019 12; 57(12):937-944.
    View in: PubMed
    Score: 0.005
  47. Social norms associated with nonmedical opioid use in rural communities: a systematic review. Transl Behav Med. 2019 11 25; 9(6):1224-1232.
    View in: PubMed
    Score: 0.005
  48. Multicenter Outbreak of Gram-Negative Bloodstream Infections in Hemodialysis Patients. Am J Kidney Dis. 2019 11; 74(5):610-619.
    View in: PubMed
    Score: 0.005
  49. Prescription Opioid Use in a Population-Based Sample of Young Black Men Who Have Sex with Men: A Longitudinal Cohort Study. Subst Use Misuse. 2019; 54(12):1991-2000.
    View in: PubMed
    Score: 0.005
  50. Identifying Areas with Disproportionate Local Health Department Services Relative to Opioid Overdose, HIV and Hepatitis C Diagnosis Rates: A Study of Rural Illinois. Int J Environ Res Public Health. 2019 03 19; 16(6).
    View in: PubMed
    Score: 0.005
  51. The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention Behaviors. Infect Control Hosp Epidemiol. 2017 11; 38(11):1351-1357.
    View in: PubMed
    Score: 0.004
  52. Cost-effectiveness of meglumine antimoniate versus miltefosine caregiver DOT for the treatment of pediatric cutaneous leishmaniasis. PLoS Negl Trop Dis. 2017 04; 11(4):e0005459.
    View in: PubMed
    Score: 0.004
  53. Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants. AIDS. 2017 01 02; 31(1):81-88.
    View in: PubMed
    Score: 0.004
  54. Shared Decision Making Among Clinicians and Asian American and Pacific Islander Sexual and Gender Minorities: An Intersectional Approach to Address a Critical Care Gap. LGBT Health. 2016 10; 3(5):327-34.
    View in: PubMed
    Score: 0.004
  55. Expanded HIV Testing and Linkage to Care: Conventional vs. Point-of-Care Testing and Assignment of Patient Notification and Linkage to Care to an HIV Care Program. Public Health Rep. 2016 Jan-Feb; 131 Suppl 1:107-20.
    View in: PubMed
    Score: 0.004
  56. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 05; 162(9):619-29.
    View in: PubMed
    Score: 0.004
  57. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study. AIDS Res Hum Retroviruses. 2013 Jun; 29(6):931-7.
    View in: PubMed
    Score: 0.003
  58. Efficacy of a six-month versus a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial. PLoS One. 2012; 7(12):e47400.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.